Granite Point Capital Management, L.P. Tandem Diabetes Care Inc Call Options Transaction History

Granite Point Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 05, 2021	BUY	$86.4 - $121.75 $4.75 Million - $6.7 Million	55,000 Added 275.0%	75,000 $7.18 Million
Q3 2020 Nov 06, 2020	SELL	$95.43 - $116.09 $7.63 Million - $9.29 Million	-80,000 Reduced 80.0%	20,000 $2.27 Million
Q4 2018 Feb 05, 2019	SELL	$28.45 - $40.65 $4.27 Million - $6.1 Million	-150,000 Reduced 60.0%	100,000 $3.8 Million
Q3 2018 Nov 13, 2018	BUY	$21.39 - $51.17 $5.35 Million - $12.8 Million	250,000 New	250,000 $10.7 Million

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.94B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.